Noxiptiline
Noxiptiline, also known as noxiptyline and dibenzoxine, is a tricyclic antidepressant that was introduced in Europe in the 1970s for the treatment of depression. It has imipramine-like effects, acting as a serotonin and norepinephrine reuptake inhibitor, among other properties. Of the TCAs, noxiptiline has been described as one of the most effective, rivaling amitriptyline in clinical efficacy.